Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹26,916.1
₹57,195 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,028.9
₹37,842 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹470.9
₹7,411 Cr
Pharmaceuticals & Drugs
₹650.8
₹5,900 Cr
Pharmaceuticals & Drugs
₹347.8
₹3,174 Cr
Pharmaceuticals & Drugs
₹277.8
₹3,109 Cr
Pharmaceuticals & Drugs
₹81.1
₹2,081 Cr
Pharmaceuticals & Drugs
₹679.9
₹388 Cr
Pharmaceuticals & Drugs
₹65.0
₹184 Cr
Pharmaceuticals & Drugs
₹32.5
₹158 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,028.9
₹5,202 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹470.9
₹4,257 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹347.8
₹2,522 Cr
Pharmaceuticals & Drugs
₹650.8
₹1,801 Cr
Pharmaceuticals & Drugs
₹277.8
₹710 Cr
Pharmaceuticals & Drugs
₹81.1
₹240 Cr
Pharmaceuticals & Drugs
₹32.5
₹129 Cr
Pharmaceuticals & Drugs
₹26,916.1
₹6,824 Cr
Pharmaceuticals & Drugs
₹679.9
₹323 Cr
Pharmaceuticals & Drugs
₹65.0
₹391 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,028.9
₹1,015 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹470.9
₹325 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹650.8
₹211 Cr
Pharmaceuticals & Drugs
₹347.8
₹202 Cr
Pharmaceuticals & Drugs
₹277.8
₹155 Cr
Pharmaceuticals & Drugs
₹81.1
₹140 Cr
Pharmaceuticals & Drugs
₹32.5
₹5 Cr
Pharmaceuticals & Drugs
₹26,916.1
₹1,524 Cr
Pharmaceuticals & Drugs
₹679.9
₹10 Cr
Pharmaceuticals & Drugs
₹65.0
₹3 Cr

You may also like the below Video Courses